All In Biotech

Drug Trial Radar · NCT04802733

Phase 1 Safety and Tolerability Study of MSK-DA01 Cell Therapy for Advanced Parkinson's Disease

Phase 1 Study To Assess the Safety and Tolerability of Human Embryonic Stem Cell-Derived Midbrain Dopamine Neuron Cell Therapy (MSK-DA01) For Advanced Parkinson's Disease

Last checked: Nov 20, 2026Latest source record: Nov 1, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

12

Actual

Start

May 3, 2021

Primary completion

May 18, 2023

Study completion Jun 10, 2024

Sponsor

Lead sponsor
BlueRock TherapeuticsIndustry
Sponsor type
Industry
Collaborators
Memorial Sloan Kettering Cancer Center
First posted
Mar 17, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 50 years, up to 78 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This clinical trial is designed to test whether surgically injecting nerve cells that make dopamine into the brain of Parkinson's disease patients is safe, and to monitor for potential side effects.

Conditions

  • Advanced Parkinson's Disease

Interventions

  • MSK-DA01Biological

    MSK-DA01 is an experimental product derived from human embryonic stem cells. The stem cells were converted into brain cells that produce dopamine.

  • MSK-DA01 Cell Delivery DeviceDevice

    A device that is used for injection of fluids into the brain will be used. Some minor modifications have been made to the device to allow delivery of MSK-DA01 cells.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety and TolerabilityTime frame: Baseline to 1 Year Post-Transplant

Locations

3 sites in 2 countries. Site status is shown where the registry gives one.

  • University of California Irvine

    Orange, California

  • Weill Cornell Medical College

    New York, New York

  • Toronto Western Hospital

    Toronto, Ontario, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.